🇺🇸 Microgynon in United States

478 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 84 reports (17.57%)
  2. Fatigue — 69 reports (14.44%)
  3. Vomiting — 61 reports (12.76%)
  4. Dizziness — 51 reports (10.67%)
  5. Headache — 46 reports (9.62%)
  6. Malaise — 39 reports (8.16%)
  7. Drug Interaction — 36 reports (7.53%)
  8. Dyspnoea — 32 reports (6.69%)
  9. Diarrhoea — 30 reports (6.28%)
  10. Tremor — 30 reports (6.28%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Microgynon approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Microgynon in United States?

The University of Hong Kong is the originator. The local marketing authorisation holder may differ — check the official source linked above.